Keywords: teijin, licenses, febuxostat, astellas, taiwan, pharma, licensed

Teijin licenses febuxostat to Astellas in Taiwan

Article | 14 May 2009

Print This

Teijin Pharma has licensed TMX-67 (febuxostat), a drug for treating hyperuricemia in patients with gout, to the Taiwanese sales and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in